Stock Movers: Nike Earnings, Occidental Petrochemical Deal, Pfizer Price Cuts

Nike's Turnaround and Earnings

• 👟 Nike shares are trading higher, up about 4% in pre-market trading, following strong earnings that exceeded market expectations.
• 💡 The company's turnaround efforts and strong performance in its wholesale and running shoe businesses are key drivers, despite a 1% sales dip on a currency-neutral basis.
• 📈 Wall Street analysts have responded positively, with several price target upgrades, including from Piper Sandler and JP Morgan, reflecting confidence in Nike's strategy.
• ⚠️ Nike also revised its estimate for tariff impact upwards to $1.5 billion, but the market appears to be looking past this, focusing on the turnaround plan.

Occidental Petroleum and Berkshire Hathaway

• 🤝 Occidental Petroleum (OXY) shares are up 1.4% on news that Berkshire Hathaway is nearing a deal to acquire its petrochemical business, OxyChem, for approximately $10 billion.
• 🏦 This potential deal is significant as it would be Berkshire Hathaway's largest acquisition since buying Alleghany Corp. in 2022.
• 🔗 Berkshire Hathaway has a long-standing relationship with Occidental, having previously assisted with acquisitions.

Pfizer and Pharmaceutical Sector

• 💊 Pfizer (PFE) shares are up 0.4% following an agreement with the Trump administration to slash some drug prices by up to 85% and sell directly to the American public.
• 🌍 This move is part of a broader global trend in the pharmaceutical sector, with stocks in Asia and Europe also seeing gains.
• 🚀 Pfizer may be experiencing a second wind in trading due to these developments and the global pharma rally.

Market Trends and Valuations

• 📉 Tech stocks with high valuations, such as Nvidia, Intel, and Tesla, are facing questioning and seeing some declines at the start of the month and quarter.
• 🛡️ Defense names are also being scrutinized alongside tech stocks.